Erythropoietin receptor in ovarian cancer cells - letter

Molecular Cancer Therapeutics

Volumn 9, Issue 4, 2010, Pages 1070-1071

  Swift, Susan E ^a   Elliott, Steve ^a   Sinclair, Angus M ^a   Glenn Begley, C ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; HYPERICIN; RECOMBINANT ERYTHROPOIETIN;

APOPTOSIS; CANCER CELL CULTURE; DRUG INHIBITION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; OVARY CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; CELL LINE, TUMOR; ERYTHROPOIETIN, RECOMBINANT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHOSPHORYLATION; RECEPTORS, ERYTHROPOIETIN;

EID: 77950809571     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0439     Document Type: Letter

References (5)

1. Solar P, Koval J, Mikes J, et al. Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. Mol Cancer Ther 2008;7:2263-2271
2. Jelkmann W, Bohlius J, Hallek M, Sytkowski A. The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol 2008;67:39-61.
3. Elliott S, Bass B, Spahr C, et al. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006;107:1892-1895
4. Laugsch M, Metzen E, Svensson T, Depping R, Jelkmann W. Lack of functional erythropoietin receptors of cancer cell lines. Int J Cancer 2007;122:1005-1011
5. Sinclair AM, Todd MD, Forsythe K, Knox SJ, Elliott S, Begley CG. Expression and function of erythropoietin receptors in tumors. Cancer 2007;110:477-488